Lanting Intelligent Medicine
兰丁股份
elsewhere's corpus does not cover Lanting Intelligent Medicine. The retrieved material mentions the name only as an entity card without accompanying facts, and none of the document chunks discuss the company directly.
AI-generated — may contain errors, please verify.
Coverage
Steady Steps Toward Renewal, Momentum Into Waves | DTX 2025 Annual Review
Those who walk deeper into the cycle always spot the next beam of light.
Riding the Wind, Breaking Boundaries — Tides Surge in Hong Kong | Dalton Venture 2025 CEO Summit Successfully Concludes
At the intersection of technological revolution and industrial transformation, what should be the starting point for the globalization of the life sciences industry? Where should mainland Chinese healthcare innovators set their first foothold for overseas expansion? Against a backdrop of intensifying international competition and sustained policy tailwinds, is Hong Kong — a city that blends international perspective with institutional advantages — emerging as the bridge for tech ventures to reach the world?
Over 50,000 Cases in a Single Day! Inside the Speed of Landing AI's Cervical Cancer Screening | Dalton Venture Family
Landing Med aims to automate, digitize, and scale cytological pathology diagnosis through AI-powered, cloud-based diagnostic technology — enabling intelligent, networked, and standardized early detection of high-incidence tumors.
